Paroxetine—Overview of the Molecular Mechanisms of Action
In the 21st century and especially during a pandemic, the diagnosis and treatment of depression is an essential part of the daily practice of many family doctors. It mainly affects patients in the age category 15–44 years, regardless of gender. Anxiety disorders are often diagnosed in children and a...
Main Authors: | Magdalena Kowalska, Jacek Nowaczyk, Łukasz Fijałkowski, Alicja Nowaczyk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/4/1662 |
Similar Items
-
Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters
by: Magdalena Kowalska, et al.
Published: (2021-06-01) -
Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression
by: Asma S. Alonazi, et al.
Published: (2023-12-01) -
GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
by: Monica Thapaliya, et al.
Published: (2022-10-01) -
Paroxetine in the Treatment of Post Traumatic Stress Disorder: Our Experiences
by: Abdulah Kučukalić, et al.
Published: (2008-02-01) -
Paroxetine-induced galactorrhea
by: S. Petrykiv, et al.
Published: (2022-06-01)